Brookfield Business Partners: a Plethora of Problems and Overvalued
Management said units have upside to $80, but doesn’t disclose detailed company information. Credit ratings suggests financial stress is widespread in the portfolio. Which story do you believe?
We are short Brookfield Business Partners (BBU) and Brookfield Business Corporation (BBUC).
The plethora of problems include an undisclosed SEC investigation, probable undisclosed related-party financings, and parent selling at the LP-level.
The partnerhip’s portfolio is dominated by companies are rated deep junk, hovering at just above CCC+, where default risks spike. Investment risks are highlighted with the recent failures of Healthscope and Altera Investment, and short analysis of Mulltiplex and Modulaire.
After a recent ~35% increase in the unit price, BBU trades at a premium to NAV where most comparable vehicles trade at a -30% discount.
The full report is available here:
DISCLAIMER
This report represents the opinions of Keith Dalrymple and Dalrymple Finance on Brookfield Business Partners. It is an opinion piece and should not be taken as investment advice of any kind. This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.
BBU’s web page has a list of sell-side firms that provide research coverage. The firms and analysts listed are in the business of providing investment advice to individual and institutional investors. We strongly encourage those seeking investment advice to consult one or more of the sell-side research firms listed.
The report is based on publicly available information and due diligence Dalrymple Finance believes to be accurate and reliable. However, it is presented “as is” without warranty of any kind, whether express or implied. Dalrymple Finance makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. This report contains a large measure of analysis and opinion. It is subject to change without notice.
Following the publication of this report we intend on continuing to transact in the securities. We may be long, short or have no position at any time. That position may change at any time.
We are investors with the goal of profiting from our research. You should assume that as of the publication date, that Dalrymple Finance, Keith Dalrymple and/or affiliates have a position in related securities. We and affiliates have a vested financial interest in entity discussed in this report.
In no event shall Dalrymple Finance or Keith Dalrymple be liable for any claims, losses costs or damages of any kind, including direct, indirect and otherwise, arising out of or in any way connected with information in this report.
Good research, as always!